Graduation Medical Education (GME): Autonomic Medicine

Fellowship Program Director: David S. Goldstein, MD, PhD

Qualified candidates for a Clinical Fellowship position (with privileges in the NIH Clinical Center) should be licensed to practice medicine in the United States and have a serious interest in patient-oriented clinical research. Qualified candidates for a Pre-Clinical Fellowship position should have an advanced degree in biochemistry, neurochemistry, physiology, or similar subject matter or have demonstrable skills in bench laboratory techniques relevant to the research of the Autonomic Medicine Section; and should have a serious interest in one of the above scientific topics.

Program Structure
This program in the Autonomic Medicine Section offers a clinical fellowship that is accredited by the United Council for Neurologic Subspecialties (UCNS) and trains Fellows in patient-oriented and translational research about disorders of autonomic and catecholaminergic systems. Because of the myriad roles of these systems in homeostasis, drug effects, and multi-disciplinary acute and chronic disorders of regulation, autonomic medical research requires thinking in terms of integrative physiological concepts. The clinical research consists of developing and testing diagnostic and pathophysiologic biomarkers, natural history studies, and pathophysiologically relevant therapeutic interventions. Major emphasis is on catecholaminergic deficiencies in the brain and periphery in Parkinson disease, dementia with Lewy bodies, pure autonomic failure, and other synucleinopathies evaluated by physiological, neurochemical, neuroimaging, microscopic, and genetic approaches. The translational research focuses on autotoxicity exerted by the dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) and harmful DOPAL-induced modifications of intracellular proteins such as alpha-synuclein. The program uses a variety of clinical assessment techniques such as physiological autonomic function testing, catecholamine neurochemistry, visualization of catecholaminergic innervation by positron emission tomography (PET) scanning, and immunofluorescence confocal microscopy to examine alpha-synuclein deposition in sympathetic nerves. A recent urgent extension of the research is to autonomic/catecholaminergic functions in post-acute SARS-CoV2. The section runs a world-renowned Clinical Neurochemistry Laboratory.

Areas of Current Research

  • Diagnostic biomarkers and mechanisms of catecholaminergic neurodegeneration in autonomic failure
  • Relationships of autonomic failure to non-motor and pre-motor aspects of Lewy body diseases
  • Clinical laboratory diagnosis and natural history of neurogenic orthostatic hypotension
  • Collaborative clinical and preclinical studies of autonomic rare diseases
  • Computer modeling of cardiac sympathetic functions and mechanisms of catecholamine deficiency
  • Clinical autonomic function testing
  • Collaborative clinical and preclinical studies of catecholamine systems

Application Information
Apply to this program through the NIH Graduate Medical Education Application System and check out the NINDS intramural website for more information.

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 11/04/2022

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at